Company Creative Medical Technology Holdings, Inc. Other OTC
Equities
CELZ
US22529Y2000
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stem Cell Treatments
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -89.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -89.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 16-05-17 | |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Sahil Nock
PRN | Corporate Officer/Principal | - | 22-02-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Snow
BRD | Director/Board Member | 67 | 21-12-01 |
Donald Dickerson
DFI | Director of Finance/CFO | 59 | 16-01-31 |
Chief Executive Officer | 62 | 16-05-17 | |
Michael Finger
BRD | Director/Board Member | 77 | 21-12-01 |
Bruce S. Urdang
BRD | Director/Board Member | 66 | 21-12-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,424,626 | 1,311,354 ( 92.05 %) | 76,500 ( 5.370 %) | 92.05 % |
Company contact information
Creative Medical Technology Holdings, Inc.
211 East Osborn Road
85012, Phoenix
+
http://www.creativemedicaltechnology.comSector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |